Haleon plc is a consumer healthcare company. The Companyâs product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Companyâs geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Companyâs oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.
äŒæ¥ã³ãŒãHLN
äŒç€ŸåHaleon PLC
äžå Žæ¥Jul 18, 2022
æé«çµå¶è²¬ä»»è
ãCEOãMcnamara (Brian)
åŸæ¥å¡æ°- -
蚌åžçš®é¡Depository Receipt
æ±ºç®ææ«Jul 18
æ¬ç€Ÿæåšå°Building 5, First Floor
éœåžWEYBRIDGE
蚌åžååŒæNASDAQ OMX NASDAQ Basic NYSE
åœUnited Kingdom
éµäŸ¿çªå·KT13 0NY
é»è©±çªå·441932822000
ãŠã§ããµã€ãhttps://www.haleon.com/
äŒæ¥ã³ãŒãHLN
äžå Žæ¥Jul 18, 2022
æé«çµå¶è²¬ä»»è
ãCEOãMcnamara (Brian)